Metagenomics Market to 2027 – Global Analysis & Forecasts by Product, Application and Geography – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Metagenomics
Market to 2027 – Global Analysis and Forecasts by Product, Application
and Geography” report has been added to ResearchAndMarkets.com’s
offering.

The global metagenomics market is expected to reach US$ 314.3 Mn in 2027
from US$ 165.8 in 2018. The market is estimated to grow with a CAGR of
7.7% from 2018-2027.

Driving factors such as increasing venture capital investments,
advantages of metagenomics in biotechnology and industrial applications
of metagenomics. Whereas, the trend of the extensive set of
molecular-based approaches positive impact on the growth of the market
in the coming years. However, high capital costs of metagenomics is
anticipated to restrain the market growth.

The current trend of the molecular-based approaches has enabled the
field of the metagenomics to study the uncultured microorganisms. The
metagenomics has also helped in the huge way for the clinical
diagnostics and the clinical diagnostics is the current trend going on
cross the world. Also the extensive research is been going-on currently
for the environmental sectors. Also the metagenomics have potential to
discover products for the biotechnology, agriculture biotechnology, food
technology and others.

The potential of the metagenomics in the pharmaceuticals owe to the
large hopes for growth opportunities for the market players. Also the
novel innovations from the market players are likely to discover the
solutions for the chronic infectious diseases.

The initial cost of the primary set up for the metagenomics is very
high, however, the technological advancement and the efforts by the
market leader such as Illumina Inc., Pacific Bioscience of California
Inc., among the others are likely to meet this challenge. These market
players are aggressively working to provide cost effective solutions for
the metagenomics studies. The healthcare industry is likely to
experience the positive outcomes in the coming future.

Global metagenomics market, based on the application was segmented into
clinical diagnostics, drug discovery, and other applications. Clinical
Diagnostics segment is anticipated to grow at a CAGR of 7.2% during the
forecast period. The metagenomics offers prodigious potential for the
identification of uncultured microorganism that can be used to detect
and diagnose infectious diseases and the genetic properties of the
microorganism. Therefore, the segment held the largest market share of
47.9% for the application segment in the metagenomics market and is
likely to dominate the market in coming forecast period.

Key Topics Covered

1. Introduction

1.1 Scope of the Study

1.2 Report Guidance

2. Global Metagenomics Market – Key Takeaways

3. Global Metagenomics Market – Market Landscape

3.1 Overview

3.2 Market Segmentation

3.2.1 Global Metagenomics Market – by Product

3.2.2 Global Metagenomics Market – by Application

3.2.3 Global Metagenomics Market – by Geography

3.3 Pest Analysis

3.3.1 North America – Pest Analysis

3.3.2 Europe- Pest Analysis

3.3.3 Asia Pacific- Pest Analysis

3.3.4 Middle East and Africa- Pest Analysis

3.3.5 South and Central America – Pest Analysis

4. Global Metagenomics Market – Key Market Dynamics

4.1 Key Market Drivers

4.1.1 Increasing Venture Capital Investments

4.1.2 Advantages of Metagenomics In Biotechnology

4.1.3 Industrial Applications of Metagenomics

4.2 Key Market Restraints

4.2.1 High Capital Costs of Metagenomics

4.3 Key Market Opportunities

4.3.1 Usage of Metagenomics For Precision Medicine

4.3.2 Emerging Nations

4.4 Key Market Trends

4.4.1 Extensive Set of Molecular-Based Approaches

4.5 Impact Analysis

5. Metagenomics Market – Global Analysis

5.1 Global Metagenomics Market Revenue Forecasts and Analysis

5.2 Global Metagenomics Market, by Geography – Forecasts and Analysis

5.3 Market Positioning

5.4 Performance of Key Players

5.4.1 Illumina, Inc.

5.4.2 Qiagen

5.5 Expert Opinions

6. Global Metagenomics Market Analysis – by Product

6.1 Overview

6.2 Global Metagenomics Market, by Product, 2018 & 2027 (%)

6.3 Instruments & Software Market

6.3.1 Overview

6.3.2 Global Instruments & Software Market Revenue and Forecasts To 2027
(US$ Mn)

6.4 Consumables Market

6.4.1 Overview

6.4.2 Global Consumables Market Revenue and Forecasts To 2027 (US$ Mn)

7. Global Metagenomics Market Analysis – by Application

7.1 Overview

7.2 Global Metagenomics Market, by Application, 2018 & 2027 (%)

7.3 Clinical Diagnostic Market

7.3.1 Overview

7.3.2 Global Clinical Diagnostic Market Revenue and Forecasts To 2027
(US$ Mn)

7.4 Drug Discovery Metagenomics Market

7.4.1 Overview

7.4.2 Global Drug Discovery Metagenomics Market Revenue and Forecasts To
2027 (US$ Mn)

7.5 Others Market

7.5.1 Overview

7.5.2 Global Others Market Revenue and Forecasts To 2027 (US$ Mn)

8. North America Metagenomics Market Revenue and Forecasts To
2027

9. Europe Metagenomics Market Revenue and Forecasts To 2027

10. Asia Pacific Metagenomics Market Revenue and Forecasts To
2027

11. Middle East and Africa Metagenomics Market Revenue and
Forecasts To 2027

12. South and Central America Metagenomics Market Revenue and
Forecasts To 2027

13. Metagenomics Market – Industry Landscape

13.1 Overview

13.2 Growth Strategies In the Metagenomics Market, 2015-2018

13.3 Organic Developments

13.4 Organic Growth Strategies In the Metagenomics Market, 2015-2018

13.5 Product Launch

13.6 Product Approval

13.7 Expansion & Others

13.8 Inorganic Developments

13.9 Inorganic Growth Strategies In the Metagenomics Market, 2015-2018

13.10 Acquisitions

13.11 Agreements

13.12 Partnership & Collaboration

14. Metagenomics Market – Key Company Profiles

14.1 Merck KGaA

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Financial Overview

14.1.4 Product Portfolio

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Thermo Fisher Scientific Inc.

14.3 Agilent Technologies Inc.

14.4 Qiagen

14.5 Bio-Rad Laboratories Inc.

14.6 Perkin Elmer Inc.

14.7 Illumina Inc.

14.8 F. Hoffmann-La Roche Ltd.

14.9 Oxford Nanopore Technologies Ltd.

14.10 Pacific Bioscience of California Inc.

For more information about this report visit https://www.researchandmarkets.com/r/xsldo1

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Genomics